Clinical Trials Logo

Mitral Valve Insufficiency clinical trials

View clinical trials related to Mitral Valve Insufficiency.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT06467110 Enrolling by invitation - Clinical trials for Degenerated Mitral Regurgitation

Safety and Effectiveness Study of SQ-Kyrin TMVr System for Degenerated Mitral Regurgitation

Start date: October 15, 2021
Phase: N/A
Study type: Interventional

To verify the safety and effectiveness of transcatheter mitral valve clip delivery system and steerable guide catheter produced by Shanghai Shenqi Medical Technology Co., Ltd.in patients with moderate-severe or severe degenerated mitral regurgitation (DMR).

NCT ID: NCT05931900 Enrolling by invitation - Clinical trials for Functional Mitral Regurgitation

The JensClip Transcatheter Valve Repair System for Treating Functional Mitral Regurgitation

Start date: August 2023
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of the JensClip transcatheter valve repair system for patients with moderate-severe or greater (MR ≥ 3+) functional mitral regurgitation (FMR) who have received adequate treatment but are still symptomatic.

NCT ID: NCT05677568 Enrolling by invitation - Clinical trials for Mitral Regurgitation

The CINCH-FMR Post-Market Registry: Percutaneous Repair in Functional Mitral Regurgitation

CINCH-FMR
Start date: June 24, 2017
Phase:
Study type: Observational [Patient Registry]

This is a retrospective and prospective, multi-center, post-market observational registry study. The primary objective of this post market registry is to continue to evaluate the long term safety and performance of the Carillon® Mitral Contour System® (CMCS) in a commercial (post market) setting.

NCT ID: NCT05305612 Enrolling by invitation - Atrial Fibrillation Clinical Trials

Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

STOP CLOT
Start date: March 13, 2022
Phase: Phase 4
Study type: Interventional

The transcatheter edge to edge mitral valve repair (TEER) and left atrial appendage closure (LAAC) are the interventional cardiology procedures that require periprocedural anticoagulation with unfractionated heparin (UFH). The UFH is administered either before or immediately after transseptal puncture, at the discretion of the operator The aim of the study is to establish the optimal timing of initiation of periprocedural anticoagulation in patients undergoing structural heart interventions requiring transseptal puncture (TEER and LAAC), Patients who undergo TEER implantation or LAAC procedure will be randomized to two groups: 1. Early UFH administration. The iv. bolus of UFH (100Units/kg) will be given after obtained femoral vein access and at least 5 minutes prior to the start of the TSP. 2. Late UFH administration. The iv. bolus of UFH (100Units/kg) will be given immediately after TSP, defined as the introduction of transseptal sheath into the left atrium.

NCT ID: NCT05090540 Enrolling by invitation - Clinical trials for Severe Mitral Valve Regurgitation (Disorder)

Transcatheter Versus Standard Surgical Mitral Valve Operation for Secondary Mitral Regurgitation

TEERMISO
Start date: June 1, 2022
Phase:
Study type: Observational

The mechanical intervention is treating secondary mitral regurgitation (SMR) which may be performed using the standard open surgical approach or transcatheter edge to edge repair (TEER). The key question of this study is to establish the difference in left ventricular reverse remodeling after adjustment for death, as assessed by means of the left ventricular end-systolic dimension(LVESD), all-cause and cause-specific (cardiac vs noncardiac) mortality in patients who received the TEER vs the standard surgical procedure for SMR.

NCT ID: NCT04776798 Enrolling by invitation - Low Back Pain Clinical Trials

Biomechanical Taping on Low Back Pain With Increased Foot Pronation

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

It is stated that abnormal lower extremity posture and biomechanics are effective in the development and progression of Low Back Pain (LBP). Exercise, electrotherapy, insoles, and orthoses are used for the prevention and treatment of low back pain.The use of orthosis, insoles, and taping techniques stands out in the correction of foot posture and dysfunctions, which are stated to cause LBP. In studies examining the application of taping to improve foot posture and biomechanics, it is stated that taping is effective in improving foot posture and biomechanics in the short term. Biomechanical taping has been used in the treatment of musculoskeletal disorders in recent years. It is aimed to correct the impaired joint biomechanics by reducing the load on the joint, supporting strength, and providing movement modification.

NCT ID: NCT04734756 Enrolling by invitation - Clinical trials for Degenerative Mitral Valve Disease

Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation

Start date: May 4, 2021
Phase: N/A
Study type: Interventional

To confirm the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system for the treatment of symptomatic moderate-to-severe(3+) or severe(4+) degenerative mitral regurgitation (DMR) in high surgical risk subjects.

NCT ID: NCT04528576 Enrolling by invitation - Clinical trials for Mitral Regurgitation

Dragonfly-M Early Feasibility Study

Start date: July 23, 2020
Phase: N/A
Study type: Interventional

To establish the safety and effectiveness of the DragonFly transcatheter mitral valve repair system in symptomatic patients with moderate to severe and severe mitral regurgitation who have been determined to be at an high risk of mortality with mitral valve surgery by the cardiac surgeon with concurrence by the local Heart Team

NCT ID: NCT04080362 Enrolling by invitation - Clinical trials for Mitral Regurgitation

Safety and Performance Study of the MitralStitch Repair System.

Start date: July 5, 2019
Phase: N/A
Study type: Interventional

The main objective is to assess the effectiveness and safety of the MitralStitch repair system in patients with moderate to severe and severe mitral regurgitation.

NCT ID: NCT04067635 Enrolling by invitation - Clinical trials for Mitral Regurgitation

Primary Mitral Regurgitation Repair

Start date: May 25, 2018
Phase:
Study type: Observational

This longitudinal cohort study evaluates the relationship of myocardial tissue markers characteristics assessed by cardiac MRI, with clinical measures of symptoms and functions in adults with primary mitral regurgitation. Participants are followed conservatively or may choose to undergo surgical repair at the discretion of their clinical team.